WORLD - ALL

Shares slump after federal court rules three scientists associated with Yeda Research are sole inventors of patent.

NEW YORK (Reuters) — Shares of ImClone Systems Inc. fell over 6 percent on Tuesday after a court invalidated the biotechnology company’s ownership of a key cancer drug patent.

Trading volume for ImClone (down $2.02 to $28.50, Charts) shares was heavy Tuesday, with more than 5 million shares changing hands in the first half hour of trading.

While I was in treatment for breast cancer, there were so many pills to take, once I came home from a chemo session. Since I often suffered from fuzzy thinking, or "chemo brain" I had trouble keeping track of the doses and timing, even though I used a pill organizer. Some pills were large, some were small, and some were daily, some were weekly. Here is a product review of a 7-Day Pill Organizer that has clearly marked days and 4 sections per day. This would have helped me keep track of my pill schedule!

Drug delivery system gets tests

PASADENA - Ray Natha has been fighting pancreatic cancer for four years. After his diagnosis, he underwent chemotherapy, but the drugs’ side effects - crippling nausea and fatigue, extreme anxiety before treatments and a blighted immune system - were more than he could bear.

The purpose of this article is to outline 13 ways that you can decrease your risk of developing any type of cancer. The following 13 ways to prevent cancer are presented in no particular order: